Botkin.AI attracts $1.5 million to better diagnose cancer at early stages

Botkin.AI platform was approved by Microsoft for publishing on the marketplace for use with Microsoft Azure platform. Using Microsoft Azure will help ensure a high level of security and performance for Botkin.AI users anywhere in the world.

Botkin.AI hit the short list of the Slush Singapore X Philips competition

The article describes the use of the company's patented technology to build mathematical models of patients in the tasks of predicting mortality, heart failure and chronic liver diseases (cirrhosis and fibrosis).

Several medical institutions in Russia have started using Botkin.AI platform for detecting various types of cancer and other diseases